This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

RIC Research Scientist Receives Prestigious $9 Million NIH Grant; Will Collaborate With 'Dream Team' Of Harvard, MIT In Advanced Brain Research

CHICAGO, Oct. 1, 2013 /PRNewswire/ -- In a move to dramatically accelerate brain research — and possible cures for autism, Parkinson's and stroke — the National Institutes of Health (NIH) today awarded Konrad Kording, Ph.D., research scientist at the Rehabilitation Institute of Chicago (RIC), a $9 million, five-year NIH Transformative Research Award to build a non-invasive, molecular-biologic tool to record, measure and study how the brain really works.

The award is part of NIH's "High Risk-High Reward" program and is one of just 10 Transformative Research grants awarded to scientists who propose highly-innovative approaches to major challenges facing the biomedical research community.

Kording, a neuroscientist, lead researcher at RIC and associate professor of physical medicine and rehabilitation at Northwestern University's Feinberg School of Medicine, will collaborate with a national team of scientists that include the highly-regarded Harvard microbiologist George Church and MIT neuroscientist Ed Boyden.

"NIH is excited to continue support of visionary investigators, among all career stages, pursuing science with the potential to transform scientific fields and accelerate the translation of scientific research into improved health, through the Common Fund's High Risk-High Reward Research Program," said NIH Director Francis S. Collins, M.D., Ph.D. "This program allows researchers to propose highly creative research projects across a broad range of biomedical research areas, that involve inherent risk, but have the potential for high-rewards."        

If successful, the research would allow scientists to collect simultaneously recordings of activities from all the nerve cells in the whole mouse brain. Doing so will increase the capture of this data by 100,000-fold, change profoundly how the brain is studied and accelerate efforts to understand and cure all sorts of brain diseases and conditions. The NIH-funded effort will work in parallel with President Obama's recently-announced BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. That $100 million program seeks to help researchers find new ways to treat, cure and even prevent brain disorders, such as Alzheimer's disease, epilepsy and traumatic brain injury.

Brain Cells that Record Own Activity

Currently, brain activity in mice is measured using a series of brain-implanted electrode-needles that transmit a tiny portion of neural activity to a recorder, amplifier, digitizer and computer. Kording's proposed solution would equip scientists to study the activity of all 100 million nerve cells at the same time — and do so biologically, without the use of machines to record it. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 -2.67%
FB $104.07 -5.81%
GOOG $683.57 -3.45%
TSLA $162.60 -7.26%
YHOO $27.97 -4.05%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs